NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues in the fourth quarter improved 6 percent year over year as its Specialty Diagnostics segment saw 12 percent growth.

Revenues for the quarter ended Dec. 31, 2012 totaled $3.26 billion, up from $3.09 billion a year ago, topping the consensus Wall Street estimate of $3.14 billion. Organically, revenues were up 4 percent year over year, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.